New York, NY -- (SBWIRE) -- 12/24/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC), Anworth Mortgage Asset Corporation (NYSE:ANH), Allied Nevada Gold Corp (NYSEMKT:ANV)
ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) opened the session at $0.85 and closed the session at $0.870. The stock showed a positive performance of 8.02% in previous trading session. Traded with volume of 4.56 million shares in the prior session and the average volume of the stock remained 3.43 million shares. ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors. Immunotherapy is an approach to treat cancer in which a patient’s own immune system is stimulated to target tumor antigens, which are molecular signals that the immune system uses to identify foreign bodies.
For How Long IMUC will fight for Profitability? Read This Trend Analysis report
Anworth Mortgage Asset Corporation (NYSE:ANH) opened the session at $4.13 and closed the session at $4.14. The stock showed a negative performance of -0.72% in previous trading session. Traded with volume of 2.82 million shares in the prior session and the average volume of the stock remained 1.53 million shares. The beta of the stock remained 0.33. Anworth Mortgage Asset Corporation (Anworth) is a real estate investment trust (REIT). The Company is engaged in the business of investing primarily in United States, or the United States agency mortgage-backed securities (agency MBS). The Company’s operations consist of portfolios, including agency mortgage-backed securities (Agency MBS) and non-agency mortgage-backed securities (Non-Agency MBS). Approximately 99.99% of the Company’s total portfolio consists of Agency MBS.
Why Should Investors Buy ANH After the Recent Fall? Just Go Here and Find Out
Allied Nevada Gold Corp (NYSEMKT:ANV) the stock advanced 0.31% and finished the session at $3.22. Traded with volume of 2.25 million shares in the prior session and the average volume of the stock remained 3.45 million shares. The beta of the stock remained 1.03. Allied Nevada Gold Corp. (Allied Nevada) is a gold and silver producer focused on mining, development, and exploration of properties in the state of Nevada. The Company’s operating mine, the Hycroft Mine, is an open-pit gold and silver heap leach operation located 54 miles west of Winnemucca, Nevada. During the year ended December 31, 2012, the Hycroft Mine produced 136,930 ounces of gold and 794,097 ounces of silver. In addition to the Hycroft Mine, the Company has six properties which have reported other mineralized material and approximately 90 other early stage exploration properties.
Will ANV Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)